Evidence-Based Practice
Current Resources for Evidence-Based Practice, March/April 2017
Mary Kern BSN, SNM,,
Nicole S. Carlson CNM, PhD,
Mary Kern BSN, SNM,
Search for more papers by this authorMary Kern BSN, SNM,,
Nicole S. Carlson CNM, PhD,
Mary Kern BSN, SNM,
Search for more papers by this authorFirst published: 18 April 2017
Published simultaneously in the Journal of Obstetric, Gynecologic, and Neonatal Nursing. 2017;46(2).
References
- 1Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the united states, 2011-2012. JAMA. 2014; 311(8): 806-814. 10.1001/jama.2014.732
- 2 National Center for Health Statistics. Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities. Hyattsville, MD: U.S. Government Printing Office; 2016. https://www.ncbi.nlm.nih.gov/pubmed/27308685
- 3Daniels K, Daugherty J, Jones J, Mosher W. Current contraceptive use and variation by selected characteristics among women aged 15-44: United States, 2011-2013. Natl Health Stat Report. 2015(86): 1-14. https://www.ncbi.nlm.nih.gov/pubmed/26556545
- 4Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, et al. U.S. Medical Eligibility Criteria for contraceptive use, 2016. MMWR Recomm Rep. 2016; 65(3): 1-103. 10.15585/mmwr.rr6503a1
- 5Edelman AB, Carlson NE, Cherala G, Munar MY, Stouffer RL, Cameron JL, et al. Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception. 2009; 80(2): 119-127. 10.1016/j.contraception.2009.04.011
- 6Trussell J, Schwarz EB, Guthrie K. Obesity and oral contraceptive pill failure. Contraception. 2009; 79(5): 334-338. 10.1016/j.contraception.2008.11.017
- 7Grimes DA, Shields WC. Family planning for obese women: Challenges and opportunities. Contraception. 2005; 72(1): 1-4. 10.1016/j.contraception.2005.04.002
- 8Lopez LM, Chen M, Mullins S, Curtis KM, Helmerhorst FM. Steroidal contraceptives and bone fractures in women: Evidence from observational studies. Cochrane Database Syst Rev. 2012(8):CD009849. 10.1002/14651858.CD009849.pub2
- 9Yamazaki M, Dwyer K, Sobhan M, Davis D, Kim MJ, Soule L, et al. Effect of obesity on the effectiveness of hormonal contraceptives: An individual participant data meta-analysis. Contraception. 2015; 92(5): 445-452. 10.1016/j.contraception.2015.07.016
- 10Xu H, Wade JA, Peipert JF, Zhao Q, Madden T, Secura GM. Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women. Obstet Gynecol. 2012; 120(1): 21-26. 10.1097/AOG.0b013e318259565a
- 11Westhoff CL, Torgal AH, Mayeda ER, Petrie K, Thomas T, Dragoman M, et al. Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women. Am J Obstet Gynecol. 2012; 207(1): 39 e31-36. 10.1016/j.ajog.2012.04.022
- 12Lopez LM, Bernholc A, Chen M, Grey TW, Otterness C, Westhoff C, et al. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev. 2016(8):Cd008452. 10.1002/14651858.CD008452.pub4
- 13Dragoman MV, Simmons KB, Paulen ME, Curtis KM. Combined hormonal contraceptive (chc) use among obese women and contraceptive effectiveness: A systematic review. Contraception. 2016. 10.1016/j.contraception.2016.10.010
- 14Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the ortho evra/evra transdermal system: The analysis of pooled data. Fertil Steril. 2002; 77(2 Suppl 2): S13-18. https://www.ncbi.nlm.nih.gov/pubmed/11849631
- 15Horton LG, Simmons KB, Curtis KM. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review. Contraception. 2016; 94(6): 590-604. 10.1016/j.contraception.2016.05.014
- 16Chuang CH, Chase GA, Bensyl DM, Weisman CS. Contraceptive use by diabetic and obese women. Womens Health Issues. 2005; 15(4): 167-173. 10.1016/j.whi.2005.04.002
- 17Ramachenderan J, Bradford J, McLean M. Maternal obesity and pregnancy complications: A review. Aust N Z J Obstet Gynaecol. 2008; 48(3): 228-235. 10.1111/j.1479-828X.2008.00860.x
References
- 1Spinner CD, Boesecke C, Zink A, Jessen H, Stellbrink HJ, Rockstroh JK, et al. HIV pre-exposure prophylaxis (PrEP): A review of current knowledge of oral systemic HIV PrEP in humans. Infection. 2016; 44(2): 151-158. 10.1007/s15010-015-0850-2
- 2 Centers for Disease Control and Prevention. Basic statistics HIV. https://www.cdc.gov/hiv/basics/statistics.html. Updated 2016.
- 3 World Health Organization. Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations. http://www.who.int/hiv/pub/guidelines/keypopulations/en/. Updated 2014.
- 4 Centers for Disease Control and Prevention. PrEP. https://www.cdc.gov/hiv/basics/prep.html. Updated 2016.
References
- 1Hunter L. Making time and space: The impact of mindfulness training on nursing and midwifery practice. A critical interpretative synthesis. J Clin Nurs. 2016; 25(7-8): 918-929. 10.1111/jocn.13164
- 2Miller-Karas E, Leitch L. iChill. http://www.ichillapp.com/index.html. Updated 2016.
- 3 University of Massachusettes Center for Mindfulness in Medicine Health Care, and Society. History of MBSR. Shrewsbury, MA: http://www.umassmed.edu/cfm/stress-reduction/history-of-mbsr/. Updated 2016.
